|Day Low/High||1,576.23 / 1,661.27|
|52 Wk Low/High||975.00 / 1,762.92|
Some -- though not all -- of the extra hardware, software and services spending currently happening would have likely taken place at a later date.
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
It's amazing, a celebration of small business creativity unleashed by a pandemic that will never be snuffed and this wave deserves our patronage and our money.
* The bears' skepticism (and cautious market positioning) coupled with their collective cynicism towards medical and scientific innovation, and the inevitability of the curve's flattening along with an "all in" Fed, have fueled the market recovery f...
Because they could be the next Netflix or Amazon. To me that's enough.
A key chart indicates weaker momentum readings of late for the multichannel commerce platform provider, which isn't a good sign.
I don't have a cute acronym, but I guess we could say this is the GPS to find relative value.
Business is currently very good for many e-commerce and digital payments firms. But there are reasons to think that growth rates will cool later this year.
Disney's trajectory could provide a blueprint for the reopening of travel and leisure -- and how investors react.
There's more than just one factor behind a lot of the sales jumps that are being seen.
Stop apologizing, don't surrender to the gloom and tell your story with sympathy but with glory, and don't make us feel like it's a mistake to own shares in your company.
Traders and investors in SHOP should consider protecting profits or booking some of their gains.
Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.
They buy and buy and buy. The same stocks. Over and over. No end to it.
The biotech sector doesn't look anything like a bear market.
Traders should give SHOP a few days before probing the long side.
In spite of the market's epic plunge, a lot of well-known tech names are still comfortably above their 52-week lows.
This is the time to high grade your portfolio, take some losses and move to better stocks.
These companies should continue to work, while we wait for a cure or a vaccine or the darned virus to run its course.
This market's bound by earnings and a virus, and both are astonishingly subjective.
Here's how to play the high-flying stock after its earnings beat.
We play the game in front of us. We try to excel in the environment provided.
Think about where Amazon went from $76. That's where one of these favorites could go.
The tech giants are each wagering that new e-commerce and payments features for their platforms will boost ad sales.
eBay's marketplace operations are seeing little to no revenue growth amid stiff competition from Amazon and others. And it's not clear when this will change.
There is no 'tech' in tech.
SHOP's earnings per share miss should be looked at in context of a report that's overall good -- but still bulls have a challenge of holding at $300.
If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.